newsfilter
← Latest News
GlobeNewswire·

Zogenix Provides Corporate Update and Reports Third Quarter 2021 Financial Results

FINTEPLA® net product sales of $21.4 million and total revenue of $22.6 million in the third quarter, representing quarter-over-quarter increases of 22% and 20%, respectively Submitted supplemental New Drug Application (sNDA) to the U.S. Food and Drug